Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for c…
Creates a new refundable federal tax credit (new IRC §36C) of up to $5,000 for living donors of specified organs to cover donation-related costs. Eligible expenses include transplantation costs, travel/lodging, medical and follow-up care, paperwork/legal fees, and lost wages; reimbursed amounts are excluded.
Adequacy of $5,000 cap versus need for more comprehensive support
Relative to its intended legislative type, this bill creates a targeted refundable tax credit for living organ donors with defined eligible organs, covered expense categories, a statutory dollar cap, and consequential amendments to related statutes, but leaves substantive administrative, fiscal, and oversight specifics to regulation or elsewhere in the budgetary process.
Creates a new refundable federal tax credit (new IRC §36C) of up to $5,000 for living donors of specified organs to cover donation-related costs.
Eligible expenses include transplantation costs, travel/lodging, medical and follow-up care, paperwork/legal fees, and lost wages; reimbursed amounts are excluded.
Defines qualified organs, limits the credit to living donors and U.S.-lawful transplants, and amends the Public Health Service Act and National Organ Transplant Act to coordinate grants and clarify the credit’s treatment under organ-sale prohibitions.
Technocratic, narrow reform with modest fiscal cost and ethical pushback risk; passage likely if bundled or scored favorably by CBO.
Relative to its intended legislative type, this bill creates a targeted refundable tax credit for living organ donors with defined eligible organs, covered expense categories, a statutory dollar cap, and consequential amendments to related statutes, but leaves substantive administrative, fiscal, and oversight specifics to regulation or elsewhere in the budgetary process.
Adequacy of $5,000 cap versus need for more comprehensive support
These are examples from the analysis, not a ranked list of the most-affected groups.
Adequacy of $5,000 cap versus need for more comprehensive support
Generally supportive: the refundable credit reduces financial barriers for living donors and advances access to transplantation.
May view the $5,000 cap as modest and want stronger supports, plus safeguards for low-income donors.
Concerns about exploitation or insufficient follow-up care are possible but the bill’s limits and NOTA clarification are positive signs.
Pragmatically favorable: the bill addresses real financial barriers to living donation through a targeted, refundable credit.
Would seek clearer cost estimates, anti-fraud measures, and evaluation metrics.
Appreciates NOTA coordination but wants guardrails against unintended incentives and transparent budget scoring.
Skeptical: supports incentives for private charitable acts but wary of refundable credits expanding federal spending.
Concerned the credit could be perceived as payment for organs despite NOTA clarification.
Prefers private or state solutions and tighter fiscal controls.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technocratic, narrow reform with modest fiscal cost and ethical pushback risk; passage likely if bundled or scored favorably by CBO.
The bill has not accumulated any surfaced votes yet.
Adequacy of $5,000 cap versus need for more comprehensive support
Technocratic, narrow reform with modest fiscal cost and ethical pushback risk; passage likely if bundled or scored favorably by CBO.
Relative to its intended legislative type, this bill creates a targeted refundable tax credit for living organ donors with defined eligible organs, covered expense categories, a statutory dollar cap, and consequential a…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.